ZETA is an end-to-end solution provider and innovation leader for pharma & biotech and specializes in the design, automation, and qualification of customer-specific systems for pharmaceutical manufacturing. ZETA is an EPCMv contractor, drives digtialization and develops decarbonization strategies.
Products, services, technology
- EPCMv contractor
- Plant engineering
- HVAC-, cleanroom and BMS/EMS design
- Decarbonization strategies
- Automation
- Single use technologies
- Pharma 4.0 realiziation
- Digitalization
- Qualification
- Lifecycle services
- Research & Development
Cooperation possibilities
Solution provider for early and late stage development and commercial therapeutics.
- API production
- mAb production
- Blood plasma processing
- Vaccine production
- Aseptic products
- Emulsions
- Chemical synthesis
- Cell and Gene therapies
- Antibody–drug conjugate production
- Peptides production
- http://www.zeta.com
- +41 79 677 48 21
- Send an email
- Markus Siebenhaar
Some insights
- Accelerating drug development and time-to-market
- Improving the client’s digitalization journey to reduce costs for the health care systems
- Offering sustainable energy solutions and developing decarbonization strategies for clients and providing energy-efficient solutions for HVAC and utilities
- Facilitating collaborations with research institutions and pharma companies
- Providing access to skilled talent pool
- Offering innovation-friendly tax incentives
- Supporting R&D through grants and funding programs
- Enabling networking opportunities
I'm proud to work at ZETA GmbH because it embraces a fast-paced, innovative environment where we lead in developing solutions that transform pharmaceutical manufacturing. Knowing that our work makes a real difference in patients' lives fuels my passion and motivation every day.
ZETA's core strengths are End-to-end solutions for biotech/pharma, customized biopharmaceutical plant design and Innovation in Pharma 4.0 technologies. ZETA aims to integrate advanced AI, IoT, and digital twin technologies to further optimize processes and accelerate drug development.
The Swiss biotech ecosystem could support ZETA by:
With every stakeholder who shares the same vision about the pharmaceutical industry, improves patients lives faster, and owns a technology positive attitude. We would like to get in touch with experienced leaders that know the swiss market well and are open for a Pharma 4.0 solution provider.